Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 6
111
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors

&
Pages 1566-1570 | Received 24 Feb 2020, Accepted 09 Jun 2020, Published online: 24 Jun 2020

References

  • Akiyama, Y., et al., 1990. Histamine lipolysis I: changes in the free fatty acid levels of dog plasma after intravenous infusion of histamine. Methods and findings in experimental and clinical pharmacology, 12 (5), 315–324.
  • Bugajski, J. and Gadek, A., 1985. Central histaminergic stimulation of hyperlipemic response in rats under stress. Agents and actions, 16 (3–4), 236–239.
  • Clejan, S., et al., 2002. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. Journal of cellular and molecular medicine, 6 (4), 583–592.
  • Georgescu, L., Antohe, F., and Simionescu, N., 1986. The permeability of aortic endothelium to 125I-BSA in hyperlipidemic hamster. Effect of histamine and serotonin. Physiologie, 23 (4), 221–225.
  • Gonen, B., et al., 1987. Very low density lipoproteins (VLDL) trigger the release of histamine from human basophils. Biochimica et Biophysica Acta, 917 (3), 418–424.
  • Haas, M.J., et al., 2018. Inhibition of hepatic apolipoprotein A-I gene expression by histamine. European journal of pharmacology, 823, 49–57.
  • Imoto, M., et al., 1985. Predominance of histamine H1 receptors on liver plasma membrane. Biochemical and biophysical research communications, 127 (3), 885–889.
  • Iribarren, C., Tolstykh, I.V., and Eisner, M.D., 2004. Are patients with asthma at increased risk of coronary heart disease? International journal of epidemiology, 33 (4), 743–748.
  • Kareinen, I., et al., 2015. Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice. Journal of lipid research, 56 (2), 241–253.
  • Knoflach, M., et al., 2005. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Archives of internal medicine, 165 (21), 2521–2526.
  • Kovanen, P.T., 1996. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation. Current opinion in lipidology, 7 (5), 281–286.
  • Koyama, Y., et al., 1989. Effect of histamine H1-receptor antagonist on the regulation of carbohydrate and lipid metabolism in rat liver. Biochemistry international, 18 (2), 399–403.
  • Liao, W., Rudling, M., and Angelin, B., 1997. Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat. Endocrinology, 138 (5), 1863–1870.
  • Lindstedt, K.A., Mäyränpää, M.I., and Kovanen, P.T., 2007. Mast cells in vulnerable atherosclerotic plaques-a view to a kill. Journal of cellular and molecular medicine, 11 (4), 739–758.
  • Liu, X., et al., 2015. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways. Pharmacological research, 100, 36–46.
  • Rasouli, M. and Kiasari, A.M., 2008. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease. Clinical chemistry and laboratory medicine, 46 (5), 667–673.
  • Rasouli, M. and Mokhtari, H., 2017. Calculation of LDL-cholesterol vs. direct homogenous assay. Journal of clinical laboratory analysis, 31 (3), e22057.
  • Rasouli, M., Mosavi-Mehr, M., and Tahmouri, H., 2012. Liver denervation increases the levels of serum triglyceride and cholesterol via increases in the rate of VLDL secretion. Clinics and research in hepatology and gastroenterology, 36 (1), 60–65.
  • Rasouli, M., Tahmouri, H., and Mosavi-Mehr, M., 2016. The long term kinetic of plasma lipids and lipoproteins in tyloxapol injected rats. Journal of clinical and diagnostic research, 10, BF01–BF05.
  • Rasouli, M., Trischuk, T., and Lehner, R., 2004. Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. Biochimica et biophysica acta – molecular and cell biology of lipids, 1682 (1–3), 92–101.
  • Rosengard, B.R., Mahalik, C., and Cochrane, D.E., 1986. Mast cell secretion: differences between immunologic and non-immunologic stimulation. Agents and actions, 19 (3–4), 133–140.
  • Rozenberg, I., et al., 2010. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arteriosclerosis, thrombosis, and vascular biology, 30 (5), 923–930.
  • Wang, H.W., et al., 2011. Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level. Arteriosclerosis, thrombosis, and vascular biology, 31 (4), 800–807.
  • Wang, K.H., et al., 2010. Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice. The American journal of pathology, 177 (2), 713–723.
  • Yamada, S., et al., 2015. Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: histamine H1 receptors protect and H2 receptors accelerate atherosclerosis. Pathology international, 65 (2), 67–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.